UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000000531
Receipt number R000000642
Scientific Title Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
Date of disclosure of the study information 2006/11/28
Last modified on 2013/04/01 10:43:59

No. Disposal Last modified on Item of update
1 Insert 2006/11/28 17:16:38
2 Update 2008/04/17 10:59:01 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2013/04/01 10:44:00 Address
Address
Name of person sending information
Name of person sending information
Address
Address
TEL
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.